Gleaczer, 250mg/ml 4ml 3 pcs.

Cholinomimetic.

It is a precursor of acetylcholine. It mainly affects cholinergic receptors in CNS.

Glycerophosphate, which is formed during the breakdown of choline alphoscerate, is a precursor of phospholipids (phosphatidylcholine) of the neuronal membrane.

It facilitates transmission of nerve impulses in cholinergic neurons, improves neuronal membrane plasticity and receptor function.

It does not affect the reproductive cycle and has no teratogenic and mutagenic effect. Pharmacokinetics Absorption – 88%. Choline alphocerate easily passes through the blood-brain barrier.

Extracted mainly by lungs as carbon dioxide (85%) and also by the kidneys and intestines (15%).

Indications

Acute craniocerebral injury with predominantly trunk level lesions, chronic cerebrovascular insufficiency (discirculatory encephalopathy); dementia syndrome of various genesis, including Alzheimer’s disease; ischemic stroke (early and late recovery period); Gettington’s chorea; senile pseudo-melancholy.including Alzheimer’s disease; ischemic stroke (early and late recovery period); Gettington’s chorea; senile pseudomelancholia.

Active ingredient

Composition

1 ml of the solution contains:

Active ingredients:

Choline alphoscerate 250 mg,

Injection water

How to take, the dosage

Intramuscularly or intravenously slowly 1000 mg/day for 15-20 days.

In intravenous administration, the contents of one ampoule (4 ml) are diluted in saline solution.

Interaction

Significant interactions with other drugs have not been found.

Special Instructions

The dose should be reduced if nausea occurs.

Contraindications

Pregnancy, lactation, hypersensitivity to choline alphoscerate.

Side effects

Nausea, allergic reactions.

Overdose

Symptoms: nausea.

Treatment: symptomatic.

Similarities